Skip to Content
Skip to Footer
en-us
italiano
Sign In
Istituto Superiore di Sanità
Follow us on
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
MENU
Istituto Superiore di Sanità
About Us
Mission
Departments
National centres and Reference centres
Technical-scientific Services
History
Organization
Single guarantee committee
Regulations
ISS staff
Topics
Nutrition and food safety
Climate, environment and health
Dependencies
Medicines, vaccines and advanced therapies
Fertility
Gender and health
Clinical governance, National guidelines system (SNLG) and HTA
Chronic diseases and aging
Infectious diseases, HIV
Neurological diseases
Rare diseases
Prevention and health promotion
Radiation protection
Women's, children's and adolescents' health
Global health and health inequalities
Mental health
Veterinary public health
Chemical substances and health protection
Innovative technologies for health and telemedicine
Tumors
Activities
Databases
International collaborations
National Ethics Committee
Training
ISS-G20 Laboratorium
Reference laboratories
Guidelines - SNLG
Museum
Notified body
Projects
Publications
Registers and surveillance
Networks
School
Servizio Civile Universale
Phase 1 clinical trials
Services and Utilities
Meeting rooms
Calls and competitions
Library
Patronage
Intellectual property
Fares and paid services
Publications
Publications
Annali
Bollettino epidemiologico nazionale
Notiziario
Rapporti ISTISAN
Rapporti ISS Sorveglianza
ISS Activity Reports
ISS policy documents
Monographs
ISTISAN Congressi
Strumenti di riferimento
Rapporti ISS COVID-19
Rapporti ISS COVID-19 in English
Rapporti ISS COVID-19 en Español
Beni storico-scientifici
Dispense per la scuola
Consensus ISS
Leaflets
Historical videos
Ceased publications
Press Room
Home Page
About us
Press notes
News
Press releases
Press review
Special on COVID-19
Events
Digitale
Events
Conferences and seminars
Dissemination events
Webinar
ISSalute
Transparent administration
Tender notices
Data protection
Search Results - Home
Search
Search
Asset Entries
Any Asset
Web Content Article
(32)
Time
Any Time
Past Hour
(0)
Past 24 Hours
(0)
Past Week
(0)
Past Month
(16)
Past Year
(17)
Custom Range…
From
To
Search
No results were found that matched the keywords:
Omicron BA 2.75
.
Search
acque reflue 07-11 novembre 2022 conferma la presenza esclusiva della variante
Omicron
..., con prevalenza di
BA
.5 e presenza di sottovarianti BQ.1/1.1, XBB.1 e
BA
.
2.75
Web Content Article
This result comes from the Italian version of this content.
, con una prevalenza della sottovariante
BA
.5.....4/5 + R346T, BQ.1/1.1, nonché la variante
Omicron
XBB.1 e la variante...
Newsroom:
Special on COVID-19 » Acque reflue
su acque reflue 9-13 gennaio 2023 conferma la presenza esclusiva della variante
Omicron
..., con prevalenza di BQ.1* e presenza di sottovarianti
BA
.
2.75
e BN.1
Web Content Article
This result comes from the Italian version of this content.
Autonome tra il 9 e il 13 gennaio 2023 conferma la presenza esclusiva della variante
Omicron
...prevalenza della sottovariante BQ.1*, nonché la presenza minoritaria di...
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
reflue 27 novembre - 2 dicembre 2022 conferma la presenza esclusiva della variante
Omicron
..., con prevalenza di BQ.1* e presenza di sottovarianti XBB.1 e
BA
.
2.75
Web Content Article
This result comes from the Italian version of this content.
27 novembre e il 2 dicembre 2023 conferma la presenza esclusiva della variante
Omicron
...della sottovariante BQ.1*, nonché la presenza minoritaria di sottovarianti XBB.1 e...
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
reflue nel periodo 4-8 aprile 2022 conferma la presenza esclusiva della variante
Omicron
...
Omicron
....Non evidenziate mutazioni associate a
BA
.4 e
BA
.5
Web Content Article
This result comes from the Italian version of this content.
reflue fra il 4 e l’8 aprile 2022 confermano la presenza esclusiva della variante
Omicron
...e, in particolare, della sottovariante
BA
.2,...
Newsroom:
Special on COVID-19
Special on COVID-19 » Acque reflue
4 Entries
Per Page
4
Entries per Page
8
Entries per Page
20
Entries per Page
40
Entries per Page
60
Entries per Page
Showing 1 to 4 of 32 entries.
Previous Page
Page
1
Page
2
Page
3
...
Intermediate Pages Use TAB to navigate.
Page
4
Page
5
Page
6
Page
7
Page
8
Next Page
Hidden